Fig. 8

Schematic showing the proposed mechanism of Carbidopa in suppressing the growth and proliferation of AR-dependent LNCaP cells. Carbidopa could induce the activation of AHR and resultant ubiquitination and degradation of AR, therefore inhibiting proliferation and migration of AR-dependent prostate cancer cells and promoting apoptosis.